Arkolith/Insider Trading/MBX/Form 4

Pescovitz Ora H.

DirectorMBX Biosciences, Inc. (MBX) · full profile →Form 4 · filed Apr 10, 2025
Net Buying
Open-Market Buys
$45K
Open-Market Sells
$0
Net Open-Market Flow
$45K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 8, 2025Buy(P)8K$5.89$45K24K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-052685) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML